Stroke, Ischemic

Prolidase Deficiency

Bezmialem University

Prolidase Enzyme Activity in Stroke Patients

Serum Prolidase Enzyme Activity as a Diagnostic Marker for Acute Ischemic Stroke

Evaluation of serum prolidase enzyme activity in stroke patients and control group

Abdulkadir Tunc

Neurologist

Bezmialem Vakif University

Overweight

Pre Diabetes

Diabetes Mellitus Type 2 Without Complication

This was a cross-sectional study in which participants were subjected to a screening phase before being eligible to participate in the study. All subjects were submitted to Laser-Doppler methods (assessment of microcirculatory blood flow), bioimpedance analysis (assessment of body composition), venous blood collections (laboratory analysis), and Finometer Pro (assessment of heart rate variability and blood pressure variability).

Laser-Doppler methods

DPP4 Activity, Microvascular Reactivity and Inflammation

Dipeptidyl Peptidase 4 (DPP4) Activity and Its Associations With Endothelial Dysfunction, Inflammatory and Metabolic Markers, Heart Rate and Blood Pressure Variability, and Measures of Adiposity in Subjects With Different Grades of Glucose Tolerance

Intergroup analysis of the associations between DPP4 activity and skin microvascular reactivity (blood flux and vasomotion evaluated by Laser-Doppler methods) - baseline assessment and at 30 and 60 min after a standardized meal intake (ingested over 3 minutes)

Intergroup analysis of the associations between DPP4 activity and markers of inflammation - baseline assessment and at 30 and 60 min after a standardized meal intake (ingested over 3 minutes)

Intergroup comparisons between the associations of DPP4 activity and Biochemical parameters (including gut peptides) - baseline assessment and at 30 and 60 min after a standardized meal intake (ingested over 3 minutes)

Intergroup analysis of the associations between DPP4 activity and insulin resistance indexes, heart rate and blood pressure variability (evaluated by Finometer Pro), and measures of adiposity at baseline

Luiz Guilherme Kraemer-Aguiar, MD

Professor

Rio de Janeiro State University

Dipeptidyl-peptidase-4

STEMI

No-reflow

Bleeding

Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding

TIMI flow grade of <3 with a myocardial blush grade of 0-1 was defined as angiographic no-reflow

the composite of death, nonfatal MI, or stroke

defined as acute heart failure, atrial fibrillation, chest pain or re-acute myocardial infarction, complete atrioventricular block, cerebrovascular disease, ventricular fibrillation or ventricular tachycardia

defined as absolute hemoglobin drop (baseline to nadir)≥4g/dl, intracranial hemorrhage, retroperitoneal hemorrhage, use of red blood cell transfusion in patients with a baseline hemoglobin ≥9.0 g/dl, and use of red blood cell transfusion among patients with a baseline hemoglobin <9.0 g/dl and a witnessed bleeding event

atherosclerosis/proline

Prolidase Enzyme Activity in Stroke Patients

DPP4 Activity, Microvascular Reactivity and Inflammation

Plasma Dipeptidyl-peptidase-4 Activities With No-reflow and Bleeding

Hypoxia Inducible factor1-Alpha Genetic Polymorphism of Obstructive Sleep Apnea

Baza e të dhënave më e plotë e bimëve medicinale e mbështetur nga shkenca